Clinical trial NCT05111405: Study Comparing SBS and LRTI for Treatment of CMC Arthritis
Official title: A Randomized Prospective Multicenter Study Comparing Suture Button Suspensionplasty (SBS) with Ligament Reconstruction and Tendon Interposition (LRTI)
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Arthritis
Lead sponsor: Fraser Orthopaedic Research Society
Sponsor class: NETWORK
First posted: 2021-11-08
Enrollment: 138
Sex: ALL
Minimum age (years): 50
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SEQUENTIAL
Intervention model description: Multicenter, randomized, prospective trial.
Primary purpose: TREATMENT

Brief summary: A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Patient reported outcomes will be collected at 6 and 6 weeks, 3, 6, and 12 months.

Detailed description: LRTI is a well established treatment of CMC arthritis with good results.However, comparable results have also been reported with SBS, with the latter procedure eliminating the need for flexor carpi radialis (FCR) harvest and interposition, resulting in potential shorter OR time and donor site morbidity. To date, there have been biomechanical studies comparing LRTI vs suture button suspension arthroplasty (SBS), and clinical studies comparing trapeziectomy alone vs SBS, but to the best of our knowledge, no random control studies comparing LRTI with SBS.The primary objective is to determine whether treatment with SBS results in improved overall pain relief compared to LRTI as measured by patient reported outcomes.Secondary outcome measures will be to determine if SBS results in shorter OR time and improved grip and pinch strength compared to LRTI, as well as have comparable return to work times and amount of radiographic shortening as shown on radiographs (metacarpal shortening has been felt to lead to decreased grip strength).

Eligibility criteria: Inclusion Criteria:

* Age fifty years or older
* Isolated carpometacarpal (trapeziometacarpal) osteoarthritis
* Failure to respond to non-operative management
* Willing and able to consent on their own behalf and follow the protocol and clinical visits as described
* Able to read and understand English or have interpreter available

Exclusion Criteria:

* Previous surgery for CMC arthritis
* Duration of symptoms for less than 6 months
* Greater than or equal to 30 degrees of ipsilateral metacarpophalangeal (MCP) hyperextension
* Scaphotrapeziotrapezoidal (stage 4 CMC) arthritis
* Other significant ipsilateral wrist or hand pathology
* A history of inflammatory arthropathy
* A requirement for concomitant surgery for another condition
* Any previous hand or wrist fracture
* Likely problems, in the judgement of the investigators, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged patients without adequate support, etc.)

Primary outcomes:
measure: Visual Analog Scale- Pain
timeFrame: 12 Months
measure: Disabilities of the Arm, Shoulder and Hand Questionnaire
timeFrame: 12 Months
measure: Patient Related Wrist Evaluation Questionnaire
timeFrame: 12 Months
Secondary outcomes:
measure: Operative Time
timeFrame: Intraoperative
measure: Strength
timeFrame: 12 Months
measure: Range of Motion
timeFrame: 12 Months
measure: Work Productivity and Activity Impairment: Specific Health Problem Questionnaire
timeFrame: 12 Months
Other outcomes:
Locations:
city: Calgary
country: Canada
facility: South Campus Research Unit for Bone and Soft Tissue
state: Alberta
city: New Westminster
country: Canada
facility: Fraser Orthopaedic Research Society
state: British Columbia
Study officials:
References: